Indian Journal of Endocrinology and Metabolism

: 2012  |  Volume : 16  |  Issue : 1  |  Page : 67--71

Metabolic syndrome in the Middle East

Hamdy Ahmed Sliem1, Seham Ahmed1, Nader Nemr2, Iman El-Sherif1 
1 Department of Internal Medicine, Suez Canal University, Egypt
2 Department of Endemic and Infectious Disease, Suez Canal University, Egypt

Correspondence Address:
Hamdy Ahmed Sliem
Ismailia, Post code 41522

Metabolic syndrome (MS) is a combination of medical disorders that, in concert, increase the risk of developing cardiovascular disease and diabetes. It affects about one in four people in the Middle East, and prevalence increases with age. The aim of current review is to discuss the prevalence of MS and its component in different regions in the Middle East. The recorded high prevalence of the MS and its key cardiovascular risk factors (15-60%) among Middle East population mandates the need for a national and international prevention programs to combat obesity, diabetes, hypertension, dyslipidemia, smoking and related comorbidities. Consideration of early prevention and control is of utmost importance.

How to cite this article:
Sliem HA, Ahmed S, Nemr N, El-Sherif I. Metabolic syndrome in the Middle East.Indian J Endocr Metab 2012;16:67-71

How to cite this URL:
Sliem HA, Ahmed S, Nemr N, El-Sherif I. Metabolic syndrome in the Middle East. Indian J Endocr Metab [serial online] 2012 [cited 2020 Jul 3 ];16:67-71
Available from:;year=2012;volume=16;issue=1;spage=67;epage=71;aulast=Sliem;type=0